WHITE PAPERS

Determining KOL Status – Are We Overpaying HCPs?

07.15.13 | BY Andy Bender
Key Opinion Leader (KOL) evaluation models have long been used by pharmaceutical companies to justify paying premium fees to HCPs. However, companies sometimes utilize KOL models with significant practical limitations, Read more